BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Oct 07, 13:24Prev. Close
11.37
Open Price
11.37
Bid Price (Qty.)
11.34 (60)
Offer Price (Qty.)
11.39 (500)
Cash Flow of Vaishali Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 1.23 | 0.93 | 8.85 | 5.73 | 1.40 | |
Net CashFlow From Operating Activities | -18.04 | 0.81 | 1.08 | 1.32 | 2.01 | |
Net Cash Used In Investing Activities | -0.19 | 1.20 | 0.28 | -0.85 | -0.11 | |
Net Cash Used From Financing Activities | 18.49 | -1.42 | -1.73 | 0.42 | -1.81 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 0.26 | 0.59 | -0.37 | 0.89 | 0.09 | |
Cash And Cash Equivalents Begin of Year | 1.58 | 0.98 | 1.36 | 0.47 | 0.38 | |
Cash And Cash Equivalents End Of Year | 1.84 | 1.58 | 0.98 | 1.36 | 0.47 |
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y